Get the Stockscreener App
73.02
1.99%
-1.48
After Hours:
73.02
Solventum Corp stock is traded at $73.02, with a volume of 555.21K.
It is down -1.99% in the last 24 hours and down -1.35% over the past month.
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.
See More
Previous Close:
$74.50
Open:
$74.47
24h Volume:
555.21K
Relative Volume:
0.68
Market Cap:
$12.61B
Revenue:
$8.26B
Net Income/Loss:
$66.00M
P/E Ratio:
198.32
EPS:
0.3682
Net Cash Flow:
$1.17B
1W Performance:
-1.64%
1M Performance:
-1.35%
6M Performance:
+22.39%
1Y Performance:
+0.00%
1-Day Range:
$72.41
$74.72
1-Week Range:
$72.41
$75.19
52-Week Range:
$47.16
$77.17
Solventum Corp Stock (SOLV) Company Profile
Name
Solventum Corp
Sector
Industry
Phone
651-733-1110
Address
C/O 3M COMPANY, ST. PAUL
Compare SOLV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
73.02 | 12.61B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
VEEV
Veeva Systems Inc
|
225.79 | 36.66B | 2.66B | 665.91M | 1.08B | 4.05 |
|
DOCS
Doximity Inc
|
72.37 | 13.58B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
68.09 | 10.72B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
108.60 | 9.41B | 1.15B | 96.70M | -161.99M | 1.09 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Oct-08-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Neutral |
| Sep-26-24 | Initiated | Wolfe Research | Peer Perform |
| Sep-05-24 | Initiated | BTIG Research | Neutral |
| Jun-24-24 | Initiated | Argus | Hold |
| May-30-24 | Initiated | Goldman | Sell |
| May-10-24 | Initiated | BofA Securities | Neutral |
| Apr-10-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-08-24 | Initiated | Wells Fargo | Equal Weight |
| Apr-02-24 | Initiated | Edward Jones | Hold |
View All
Solventum Corp Stock (SOLV) Latest News
Kornitzer Capital Management Inc. KS Sells 5,561 Shares of Solventum Co. (NYSE:SOLV) - MarketBeat
Philip James Wealth Mangement LLC Lowers Stock Position in Solventum Co. (NYSE:SOLV) - MarketBeat
Nelson Peltz's Trian Fund boosts U-Haul, Solventum stakes in Q4 top moves - MSN
Strategic Financial Concepts LLC Makes New Investment in Solventum Co. (NYSE:SOLV) - MarketBeat
Solventum Co. (NYSE:SOLV) Shares Bought by New York State Teachers Retirement System - MarketBeat
3M health care spin-off Solventum requests $13 million from state to move to Eagan - MSN
Solventum Co. (NYSE:SOLV) Shares Sold by AustralianSuper Pty Ltd - MarketBeat
Are Wall Street Analysts Predicting Solventum Stock Will Climb or Sink? - MSN
Are Wall Street Analysts Predicting Solventum Stock Will Climb Or Sink? - Barchart
Sumitomo Mitsui Trust Group Inc. Decreases Stock Holdings in Solventum Co. (NYSE:SOLV) - MarketBeat
Solventum (NYSE:SOLV) Shares Unloaded Rep. Julie Johnson - MarketBeat
Strategic Financial Concepts LLC Buys Shares of 14,992 Solventum Co. (NYSE:SOLV) - MarketBeat
Solventum Corporation (SOLV): Among the Health Information Services Stocks Outpacing the Market in 2025 - Insider Monkey
MMMSolventum Hosts Inaugural Investor Day Ahead of Its Planned Spinoff from 3M - br.ADVFN.com
Mirae Asset Global Investments Co. Ltd. Purchases 21,362 Shares of Solventum Co. (NYSE:SOLV) - MarketBeat
Enhance your aligner offering with revolutionary aligner attachments - Dentistry.co.uk
MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers - GlobeNewswire Inc.
Solventum Corp. stock falls Friday, underperforms market - MarketWatch
Solventum (SOLV) Projected to Post Earnings on Thursday - MarketBeat
Brokerages Set Solventum Co. (NYSE:SOLV) Price Target at $68.29 - MarketBeat
Forsta AP Fonden Makes New $1.88 Million Investment in Solventum Co. (NYSE:SOLV) - MarketBeat
Pacer Advisors Inc. Has $740,000 Stock Holdings in Solventum Co. (NYSE:SOLV) - MarketBeat
Swedbank AB Cuts Stock Position in Solventum Co. (NYSE:SOLV) - MarketBeat
Solventum Fluency for Imaging clinches top spot again: Ranked #1 Best in KLAS for Speech Recognition: Front-end Imaging - The Malaysian Reserve
Solventum Fluency for Imaging clinches top spot again: Ranked #1 Best in KLAS for Speech Recognition: Front-end Imaging – Company AnnouncementFT.com - Financial Times
Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch
3M Completes Health Care Spinoff, and a Court Finalizes 'Forever Chemicals' Settlement - MSN
Solventum (SOLV) Expected to Announce Earnings on Thursday - MarketBeat
Exchange Traded Concepts LLC Grows Position in Solventum Co. (NYSE:SOLV) - MarketBeat
KBC Group NV Has $15.52 Million Stock Holdings in Solventum Co. (NYSE:SOLV) - MarketBeat
SG Americas Securities LLC Has $1.27 Million Stock Holdings in Solventum Co. (NYSE:SOLV) - MarketBeat
Solventum to Report Fourth Quarter and Full Year Fiscal 2024 Ear - GuruFocus.com
Solventum to Report Fourth Quarter and Full Year Fiscal 2024 Earnings on February 27, 2025 - Marketscreener.com
Solventum Corporation (NYSE:SOLV) is largely controlled by institutional shareholders who own 63% of the company - Yahoo Finance
Indo-Asian News Service - IANS India Pvt Ltd
Solventum Corp Stock (SOLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.51%
2.95%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):